ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 171 filers reported holding ICU MED INC in Q3 2013. The put-call ratio across all filers is 2.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,536,000 | -78.4% | 8,968 | -77.6% | 0.02% | -79.0% |
| Q2 2018 | $11,737,000 | +11.6% | 39,968 | -4.1% | 0.08% | +9.5% |
| Q1 2018 | $10,517,000 | +14.7% | 41,668 | -1.9% | 0.07% | +21.3% |
| Q4 2017 | $9,173,000 | +4.1% | 42,468 | -10.4% | 0.06% | +5.2% |
| Q3 2017 | $8,809,000 | +7.7% | 47,400 | 0.0% | 0.06% | +7.4% |
| Q2 2017 | $8,177,000 | +43.2% | 47,400 | +26.7% | 0.05% | +45.9% |
| Q1 2017 | $5,711,000 | +9919.3% | 37,400 | +5242.9% | 0.04% | – |
| Q4 2014 | $57,000 | +26.7% | 700 | 0.0% | 0.00% | – |
| Q3 2014 | $45,000 | +4.7% | 700 | 0.0% | 0.00% | – |
| Q2 2014 | $43,000 | +2.4% | 700 | 0.0% | 0.00% | – |
| Q1 2014 | $42,000 | -6.7% | 700 | 0.0% | 0.00% | – |
| Q4 2013 | $45,000 | -95.9% | 700 | -95.7% | 0.00% | -100.0% |
| Q3 2013 | $1,107,000 | -34.1% | 16,300 | -30.0% | 0.00% | -40.0% |
| Q2 2013 | $1,679,000 | – | 23,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |